Synergy between RU 28965 (roxithromycin) and human neutrophils for bactericidal activity in vitro.
The in vitro effects of RU 28965 (roxithromycin), a new semisynthetic macrolide, on human neutrophil activity were compared with those of erythromycin. RU 28965, at a concentration as low as 0.1 microgram/ml, significantly enhanced the phagocytosis and killing of Staphylococcus aureus by neutrophils...
Spremljeno u:
| Izdano u: | Antimicrob Agents Chemother |
|---|---|
| Glavni autori: | , , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
American Society for Microbiology (ASM)
1986
|
| Teme: | |
| Online pristup: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC176451/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/3019233/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.30.1.137 |
| Oznake: |
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|